Chemoinformaics analysis of [(2E)-3,7-DIMETHYLOCTA-2,6-DIENYL] 2-METHYLPROPANOATE
| Molecular Weight | 224.344 | nRot | 6 |
| Heavy Atom Molecular Weight | 200.152 | nRig | 1 |
| Exact Molecular Weight | 224.178 | nRing | 0 |
| Solubility: LogS | -1.862 | nHRing | 0 |
| Solubility: LogP | 2.379 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 40.987 |
| nHD | 0 | BPOL | 26.681 |
| QED | 0.578 |
| Synth | 1.459 |
| Natural Product Likeliness | 0.771 |
| NR-PPAR-gamma | 0.771 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.013 |
| Pgp-sub | 0.001 |
| HIA | 0.006 |
| CACO-2 | -4.746 |
| MDCK | 0.0000277 |
| BBB | 0.874 |
| PPB | 0.833334 |
| VDSS | 0.242 |
| FU | 0.239482 |
| CYP1A2-inh | 0.047 |
| CYP1A2-sub | 0.51 |
| CYP2c19-inh | 0.022 |
| CYP2c19-sub | 0.577 |
| CYP2c9-inh | 0.02 |
| CYP2c9-sub | 0.957 |
| CYP2d6-inh | 0.011 |
| CYP2d6-sub | 0.193 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.043 |
| CL | 4.774 |
| T12 | 0.797 |
| hERG | 0.013 |
| Ames | 0.007 |
| ROA | 0.122 |
| SkinSen | 0.236 |
| Carcinogencity | 0.23 |
| EI | 0.99 |
| Respiratory | 0.167 |
| NR-Aromatase | 0.007 |
| Antiviral | Yes |
| Prediction | 0.798472 |